Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3244ba8390b1f290f4ba36389c82488b |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-368 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4703 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4745 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B99-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-689 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B25-10 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B20-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B25-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate |
2017-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86965244d49e01279858dd06e96eab38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54af8884f1e3cc6b094a8dd29f326040 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a74640bd3e69fc69d5e15e8b16be1c9f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ebde23580300570403d970852f8a884 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a2f869eb02fd5fa259a99ed695d7ebc |
publicationDate |
2019-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-3423834-A1 |
titleOfInvention |
Igfbp-7 as a marker in preeclampsia |
abstract |
The present invention relates to a method for diagnosing preeclampsia or a preeclampsia-related condition in a pregnant subject. The preeclampsia-related condition can be eclampsia, HELLP syndrome or proteinuria. Said method is based on the measurement of the amount of the biomarker IGFBP-7 (Insulin-like Growth Factor Binding Protein 7) in a sample from the subject and on the comparison of the measured amount to a reference. Also encompassed by the present invention are methods for assessing the severity of preeclampsia or a preeclampsia-related condition and methods for monitoring a preeclampsia or a preeclampsia-related condition in a pregnant subject. The present invention further relates to the use of the biomarker IGFBP-7 or of an agent that specifically binds to IGFBP-7 in a sample from a pregnant subject for diagnosing, for monitoring or for assessing the severity of preeclampsia or a preeclampsia-related condition. Optionally, sFlt-1, Endoglin, PIGF are determined. Finally, the present invention relates to a device adapted to carry out the method of the present invention. |
priorityDate |
2016-02-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |